secwatch.observer — SEC 8-K summary
======================================

Issuer:     GALECTIN THERAPEUTICS INC (GALT)
CIK:        0001133416
Form:       8-K
Filed at:   2022-12-01T23:59:59+00:00
Accession:  0001140361-22-043963
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Galectin Therapeutics makes presentation after Annual Meeting on December 1, 2022
--------------------------------------------------------------------------------

- Company held Annual Meeting of Stockholders virtually due to Covid-19 precautions.
- Management and Board presented after the meeting; transcript attached as Exhibit 99.1.
- Presentation included forward-looking statements with standard cautionary language.
- Transcript filed with SEC on December 1, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133416/000114036122043963/0001140361-22-043963-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133416/000114036122043963/brhc10044950_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-043963

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer